STRATIS注册研究中机械取栓失败后动脉内溶栓的应用
STRATIS为前瞻性多中心观察性研究,984例大血管闭塞急性缺血性卒中患者以Solitaire支架取栓为一线治疗,212例(21.5%)接受补救治疗,其中动脉内rtPA组83例、无动脉内rtPA组129例;动脉内rtPA组substantial再灌注(mTICI≥2b)84.7% vs 73.0%(P=.08)、良好功能预后59.2% vs 46.6%(P=.10)、死亡率13.3% vs 23.3%(P=.08)呈升高/降低趋势但均未达统计学显著,症状性颅内出血率无差异(0% vs 1.6%,P=.54)。
要点
- 机械取栓失败后动脉内rtPA补救治疗与症状性颅内出血风险增加无关(0% vs 1.6%,P=.54)。
- 动脉内rtPA组mTICI≥2b再灌注率84.7% vs 无rtPA组73.0%,差异未达统计学显著(P=.08)。
- 动脉内rtPA中位剂量4 mg(四分位距2-12 mg),多数闭塞位于M1段。
核心结论
- 机械取栓失败后以动脉内rtPA作为补救治疗未伴症状性颅内出血或死亡风险增加,但再灌注、功能预后及死亡率的组间差异均未达统计学显著;需随机临床试验明确其安全性和有效性。
研究设计与样本
- STRATIS为前瞻性、多中心、观察性研究,纳入症状发作8小时内以大血管闭塞急性缺血性卒中、以Solitaire支架取栓为一线治疗的患者984例,比较接受补救治疗时使用与不使用动脉内rtPA患者的临床和血管造影结局;机械取栓失败定义为使用任何补救治疗。
诊断标准与关键数值
- 接受补救治疗者212/984例(21.5%),其中无动脉内rtPA组83例(39.2%)、动脉内rtPA组129例(60.8%)。
- 多数闭塞为M1段:无动脉内rtPA组43.4% vs 动脉内rtPA组55.0%(P=.12)。
- 动脉内rtPA中位剂量为4 mg(四分位距2-12 mg)。
- substantial再灌注(modified TICI≥2b):动脉内rtPA组84.7% vs 无动脉内rtPA组73.0%(P=.08),差异未达统计学显著。
- 良好功能预后:动脉内rtPA组59.2% vs 无动脉内rtPA组46.6%(P=.10),差异未达统计学显著;死亡率:动脉内rtPA组13.3% vs 无动脉内rtPA组23.3%(P=.08),差异未达统计学显著;症状性颅内出血:动脉内rtPA组0% vs 无动脉内rtPA组1.6%(P=.54),无差异。
临床应用与阅片要点
- 作者结论认为,机械取栓失败后以动脉内rtPA作为补救治疗未伴症状性颅内出血或死亡风险增加;并指出需随机临床试验来明确机械取栓后动脉内溶栓作为补救治疗的安全性和有效性。
局限性
- 原文结论指出需随机临床试验来明确机械取栓后动脉内溶栓作为补救治疗的安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Recent data suggest that intra-arterial thrombolytics may be a safe rescue therapy for patients with acute ischemic stroke after unsuccessful mechanical thrombectomy; however, safety and efficacy remain unclear. Here, we evaluate the use of intra-arterial rtPA as a rescue therapy in the Systematic Evaluation of Patients Treated with Neurothrombectomy Devices for Acute Ischemic Stroke (STRATIS) registry.
MATERIALS AND METHODS: STRATIS was a prospective, multicenter, observational study of patients with acute ischemic stroke with large-vessel occlusions treated with the Solitaire stent retriever as the first-line therapy within 8 hours from symptom onset. Clinical and angiographic outcomes were compared in patients having rescue therapy treated with and without intra-arterial rtPA. Unsuccessful mechanical thrombectomy was defined as any use of rescue therapy.
RESULTS: A total of 212/984 (21.5%) patients received rescue therapy, of which 83 (39.2%) and 129 (60.8%) were in the no intra-arterial rtPA and intra-arterial rtPA groups, respectively. Most occlusions were M1, with 43.4% in the no intra-arterial rtPA group and 55.0% in the intra-arterial rtPA group (P = .12). The median intra-arterial rtPA dose was 4 mg (interquartile range = 2-12 mg). A trend toward higher rates of substantial reperfusion (modified TICI ≥ 2b) (84.7% versus 73.0%, P = .08), good functional outcome (59.2% versus 46.6%, P = .10), and lower rates of mortality (13.3% versus 23.3%, P = .08) was seen in the intra-arterial rtPA cohort. Rates of symptomatic intracranial hemorrhage did not differ (0% versus 1.6%, P = .54).
CONCLUSIONS: Use of intra-arterial rtPA as a rescue therapy after unsuccessful mechanical thrombectomy was not associated with an increased risk of symptomatic intracranial hemorrhage or mortality. Randomized clinical trials are needed to understand the safety and efficacy of intra-arterial thrombolysis as a rescue therapy after mechanical thrombectomy.
引用
- Zaidi SF, Castonguay AC, Zaidat OO, et al. Intra-Arterial Thrombolysis after Unsuccessful Mechanical Thrombectomy in the STRATIS Registry. AJNR Am J Neuroradiol. 2021. PMID: 33509921. doi:10.3174/ajnr.A6962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。